Rankings
▼
Calendar
PMVP Q3 2025 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PMVP
PMV Pharmaceuticals, Inc.
$88M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$32,000
Operating Income
-$23M
Net Income
-$21M
EPS (Diluted)
$-0.40
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$134M
Total Liabilities
$13M
Stockholders' Equity
$121M
Cash & Equivalents
$36M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$32,000
$0
—
Operating Income
-$23M
-$22M
-2.9%
Net Income
-$21M
-$19M
-9.5%
← FY 2025
All Quarters